secwatch.observer — SEC 8-K summary
======================================

Issuer:     Arcadia Biosciences, Inc. (RKDA)
CIK:        0001469443
Form:       8-K
Filed at:   2022-08-16T23:59:59+00:00
Accession:  0000950170-22-017516
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Arcadia Biosciences raises ~$5M via registered direct offering of common stock and warrants
--------------------------------------------------------------------------------

- Sold 4,722,506 shares at $1.05876 per share plus pre-funded warrants to an institutional investor.
- Issued investment options for 4,722,506 shares at $0.93376, exercisable immediately for 5 years.
- H.C. Wainwright earned a 6% cash fee (est. $300K) plus warrants for 236,125 shares at $1.3235.
- Closing occurred August 16, 2022; offering priced at-the-market under Nasdaq rules.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1469443/000095017022017516/0000950170-22-017516-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1469443/000095017022017516/rkda-20220812.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-017516

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer